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2-Keto-3-deoxygluconate (KDG) is one of the important
intermediates in pectin metabolism. An enzyme involved
in this pathway, 3-dehydro-3-deoxy-d-gluconate 5-dehydro-
genase (DDGDH), has been identified which converts 2,5-
diketo-3-deoxygluconate to KDG. The enzyme is a member of
the short-chain dehydrogenase (SDR) family. To gain insight
into the function of this enzyme at the molecular level, the first
crystal structure of DDGDH from Thermus thermophilusHB8
has been determined in the apo form, as well as in complexes
with the cofactor and with citrate, by X-ray diffraction
methods. The crystal structures reveal a tight tetrameric
oligomerization. The secondary-structural elements and
catalytically important residues of the enzyme were highly
conserved amongst the proteins of the NAD(P)-dependent
SDR family. The DDGDH protomer contains a dinucleotide-
binding fold which binds the coenzyme NAD+ in an
intersubunit cleft; hence, the observed oligomeric state might
be important for the catalytic function. This enzyme prefers
NAD(H) rather than NADP(H) as the physiological cofactor.
A structural comparison of DDGDH with mouse lung
carbonyl reductase suggests that a significant difference in
the –loop– region of this enzyme is associated with the
coenzyme specificity. The structural data allow a detailed
understanding of the functional role of the conserved catalytic
triad (Ser129–Tyr144–Lys148) in cofactor and substrate
recognition, thus providing substantial insights into DDGDH
catalysis. From analysis of the three-dimensional structure,
intersubunit hydrophobic interactions were found to be
important for enzyme oligomerization and thermostability.
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PDB references: DDGDH,
native form I, 4jp2; native
form II, 2ekq; cofactor
complex, 2ekp; citrate
complex, 4jp3
1. Introduction
NAD/NAD(P)+-dependent glucose dehydrogenase (GlcDH)
is an enzyme distributed in a wide variety of prokaryotic
organisms. Based on sequence and structural similarities,
two unique families of GlcDHs corresponding to short-chain
dehydrogenases/reductases (SDRs) and medium-chain
dehydrogenases/reductases (MDRs) have been identified.
Members of the MDR superfamily, with a protomer molecular
weight of approximately 40 kDa, contain structural and cata-
lytic zinc ions (Jo¨rnvall et al., 1987; John et al., 1994). In
contrast, proteins of the SDR superfamily have protomers of
molecular weight between 25 and 30 kDa (Jo¨rnvall et al., 1995;
Oppermann et al., 2003). The MDR and SDR enzymes are
structurally related and have a common dinucleotide-binding
motif (Rossmann fold; Rossmann et al., 1973); however, the
active-site structure and reaction mechanism are dissimilar,
indicating functional divergence. SDR enzymes have received
much attention as they constitute a large and diverse group of
NAD(H)-dependent or NADP(H)-dependent oxidoreductase
protein family enzymes with low amino-acid sequence simi-
larity and are found in all life forms, with several genes being
found in the human genome (Jo¨rnvall et al., 1995; Oppermann
et al., 2001; Kallberg et al., 2002; Korozowski, 1992). All
available three-dimensional structures display a highly similar
/-fold pattern. Most of them are homotetrameric or
homodimeric in quaternary structure (Varughese et al., 1992;
Ghosh et al., 1994; Tanaka et al., 1996), with the exception of
porcine carbonyl reductase, which is monomeric (Ghosh et al.,
2001).
With over 2500 sequences annotated in databases and about
540 crystal structures determined, a general picture of the
SDR architecture and catalytic mechanism is emerging.
Considering all of the sequences, no strict positional conser-
vation is noted. However, multiple sequence alignments
revealed several consensus motifs, the most conserved being
the N-terminal TGXXXGXG motif starting from Thr8 that
forms part of the nucleotide-binding fold. The active-site
Ser–Tyr–Lys triad, identified through structural alignments
and functional analyses, reveals the critical involvement of
conserved elements for coenzyme binding, maintenance of
the SDR scaffold and catalysis. Some structures of proteins
unrelated in sequence but displaying the SDR fold have
considerably extended the understanding of the structure–
function relationship. Thus, the SDR domain structure
appears to be a generic scaffold that includes not only dehy-
drogenase/reductase, lyase, epimerase and hydratase activ-
ities, but also RNA-binding proteins, kinases and transcription
factors (Stammers et al., 2001). Greater understanding of the
mechanistic and structural principles governing the SDR
architecture will reveal novel protein–substrate and protein–
protein interactions and will facilitate the development of
inhibitors directed against biologically relevant SDR targets.
2-Keto-3-deoxygluconate (KDG) is one of the important
intermediates in pectin metabolism. We identified an enzyme
involved in this pathway, 3-dehydro-3-deoxy-d-gluconate
5-dehydrogenase (DDGDH), which converts 2,5-diketo-
3-deoxygluconate (DDG) to KDG, as a member of the SDR
family (Fig. 1). To gain insight into the function of this enzyme,
its catalytic mechanism and its structural rearrangement,
which is presumably important for catalysis, we determed the
crystal structure of DDGDH from Thermus thermophilus
HB8. We describe here for the first time the crystal structure
of DDGDH from T. thermophilus HB8 in two apo forms and
in NAD+-bound and citrate-bound forms at atomic resolution.
To our knowledge, this is the first detailed three-dimensional
structural characterization of any DDGDH. Unexpectedly, we
found that T. thermophilus DDGDH binds NAD rather than
NADP as a cofactor at an intersubunit cleft.
2. Materials and methods
2.1. Protein expression and purification
The plasmid encoding the DDGDH protein, provided by
the RIKEN Genomic Sciences Center, was digested with NdeI
and BglII and the fragment was inserted into the expression
vector pET-11a linearized with NdeI and BamHI. The
recombinant plasmid was transformed into Escherichia coli
BL21(DE3) cells and was grown at 310 K in Luria–Bertani
medium containing 509 mg ml1 ampicillin for 20 h. The cells
were harvested by centrifugation at 6500 rev min1 for 5 min
at 277 K. The cell pellet was suspended in 20 mM Tris–HCl pH
8.0 containing 0.5M sodium chloride and 5 mM -mercapto-
ethanol and was then homogenized by ultrasonication. The
supernatant was heated at 343 K for 12 min and the cell debris
and denaturated protein were then removed by centrifugation
(14 000 rev min1, 30 min); the supernatant solution was used
as the crude extract for purification. The crude extract was
desalted using a HiPrep 26/10 desalting column and applied
onto a Super Q Toyopearl 650M column equilibrated with
20 mM Tris–HCl pH 8.0. The fraction containing DDGDH
was eluted with a linear gradient of 0–0.3M sodium chloride.
The protein was then dialyzed against 20 mM Tris–HCl pH
8.0 and subjected to a Resource Q column (Amersham Bio-
sciences) equilibrated with 20 mM Tris–HCl pH 8.0. Fractions
containing protein were again eluted with a linear gradient of
0–0.3M sodium chloride. The protein was desalted using a
HiPrep 26/10 desalting column with 10 mM sodium phosphate
pH 7.0 and applied onto a Bio-Scale CHT20-I column (Bio-
Rad) equilibrated with 10 mM sodium
phosphate pH 7.0. DDGDH was eluted
with a linear gradient of 10–150 mM
sodium phosphate and was subse-
quently desalted using a HiPrep 26/10
desalting column with 20 mM Tris–HCl
pH 8.0 containing 0.05M sodium
chloride and applied onto a Mono Q
column (Amersham Biosciences) equi-
librated with 20 mM Tris–HCl pH 8.0
containing 0.05M sodium chloride. The
fraction containing DDGDH was eluted
with a linear gradient of 0–0.5M sodium
chloride. The fraction containing the
protein was cooled, concentrated by
ultrafiltration (Vivaspin, 10 kDa cutoff)
and loaded onto a HiLoad 16/60
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Figure 1
Reaction scheme of DDGDH.
Superdex 75 pg column (Amersham Biosciences) equilibrated
with 20 mM Tris–HCl pH 8.0 containing 0.05M sodium
chloride. The homogeneity and the identity of the purified
sample were estimated by SDS–PAGE (Laemmli, 1970) and
N-terminal sequence analysis. Protein concentrations were
determined using the UVmethod and a Bio-Rad protein assay
based on the Bradford dye-binding procedure using bovine
serum albumin as a standard. Finally, the purified DDGDH
was concentrated to 20.0 mg ml1 by ultrafiltration and was
stored at 203 K.
The oligomeric state of purified DDGDH was examined
by a dynamic light-scattering experiment performed using
a DynaPro MS/X instrument (Protein Solutions). The
measurements were obtained at 291 K using the purified
protein at 1 mg ml1 in buffer solution consisting of 20 mM
Tris–HCl, 200 mM sodium chloride. Several measurements
were taken and analyzed by the DYNAMICS software (v.3.30;
Protein Solutions). A bimodal analysis resulted in a molecular
weight of 98 kDa, which is consistent with a tetrameric form of
the protein in solution.
2.2. Crystallization
Diffraction-quality crystals were grown at room tempera-
ture by the sitting-drop method by mixing equal volumes
(1 ml) of protein solution and reservoir solution. Initial crys-
tallization conditions were established using screening kits
from Hampton Research (Jancarik & Kim, 1991). Apo forms I
and II were obtained with solutions consisting of 0.1M sodium
acetate pH 4.8, 2.0M sodium formate and 0.1M citrate–HCl
pH 5.7, 0.2M ammonium sulfate, 16.5%(w/v) polyethylene
glycol (PEG) 20 000, respectively. Crystals of the DDGDH
complex with cofactor were successfully obtained with the
protein sample adjusted to 15.0 mg ml1
and were incubated with 5 mM -NAD+
(Sigma) overnight. Crystals of the
DDGDH–NAD+ complex were grown
using a reservoir solution consisting of
0.1M Bicine pH 9.0, 2% dioxane, 10%
PEG 20 000. We also attempted to
cocrystallize DDGDH with KDG by
incubating the protein sample with
5 mM KDG overnight, but obtained
only citrate-bound crystals. Citrate-
bound crystals were grown using a
reservoir solution containing 1.6M
trisodium citrate dihydrate pH 6.5. All
of the above crystals appeared within a
week and grew to typical dimensions of
0.3  0.2  0.3 mm.
2.3. Data collection, processing and
characterization of crystals
All X-ray diffraction data sets were
collected on beamline BL26B1 at
SPring-8, Japan under cryogenic condi-
tions. Crystals were flash-cooled with
liquid nitrogen at 100 K in their respective mother liquor or in
a soaking solution containing 30%(v/v) glycerol as the cryo-
protectant. A Rigaku image-plate detector was used for data
collection. The data were indexed and scaled with the HKL
package (Otwinowski & Minor, 1997). The data sets were
completed by including all possible hkl and Rfree columns
using UNIQUE from the CCP4 suite (Winn et al., 2011). Care
was taken to keep the same Rfree flags in all data sets. Structure
factors were calculated with the program TRUNCATE from
the CCP4 suite. Data-collection parameters and processing
statistics are given in Table 1.
2.4. Structure determination
Molecular replacement (Bru¨nger et al., 1998) was
performed using a trimmed model of the structure of Ther-
motoga maritima DDGDH (PDB entry 1vl8; Joint Center for
Structural Genomics, unpublished data) as the search model.
The sequence identity between the DDGDHs from Thermus
thermophilus and Thermotoga maritima is 37%. To minimize
the bias caused by the search model, we modified the search
model based on sequence alignment. Low sequence similarity
and sequence gaps were eliminated from the model. The
orientation of the search model was determined by a fast
rotation function calculated using CNS (Bru¨nger et al., 1998)
using data between 15 and 4 A˚ resolution. The best solution
from the cross-rotation search scored 2.15 above the mean.
This peak gave a clear solution in the translation search in
space group P42212 for the apo form I crystal. Subsequently, a
refined monomer of the apo form I of DDGDH was used as
the phasing model in a molecular-replacement search for
the apo form II, cofactor-complex and citrate-complex crys-
tals. The cofactor-bound and citrate-bound crystals were
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Table 1
Crystal data, data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Apo form I Apo form II
NAD+-bound
form
Citrate-bound
form
Data statistics
Space group P42212 P41212 I222 I222
Unit-cell parameters (A˚) a = b = 62.9,
c = 114.3
a = b = 110.5,
c = 200.8
a = 66.8, b = 87.2,
c = 92.1
a = 66.9, b = 86.9,
c = 91.7
VM (A˚
3 Da1) 2.2 3.0 2.6 2.6
Content of the asymmetric unit Protomer Tetramer Protomer Protomer
Resolution (A˚) 50.0–1.15
(1.19–1.15)
50.0–1.80
(1.86–1.80)
50.0–1.15
(1.19–1.15)
50.0–1.50
(1.55–1.50)
Reflections (measured/unique) 763174/79896 628072/114641 502279/94728 278041/42860
Rmerge† (%) 7.1 (14.8) 6.6 (24.4) 6.2 (24.9) 6.1 (29.1)
Completeness (%) 99.8 (99.7) 99.3 (100.0) 99.1 (98.1) 99.4 (96.4)
hI/(I)i 16.6 (13.7) 10.5 (6.4) 10.1 (6.6) 8.5 (2.6)
Multiplicity 9.6 5.5 5.3 6.5
Refinement statistics
Resolution (A˚) 40.0–1.40 40.0–1.80 40.0–1.15 40.0–1.50
Rcryst (%) 18.9 18.4 16.8 16.3
Rfree (%) 19.9 20.8 16.8 17.8
R.m.s.d., bond lengths () 0.004 0.004 0.005 0.004
R.m.s.d., bond angles (A˚) 1.15 1.20 1.10 1.20
Ramachandran plot (%)
Most favoured 89.9 90.3 90.5 89.9
Additionally allowed 10.1 9.7 9.5 10.1
Generously allowed 0.0 0.0 0.0 0.0
isomorphous, even though they were
grown in different crystallization
conditions.
2.5. Crystallographic refinement,
density modification and model
building
The initial R factor of the apo form I
DDGDH structure was 52.5% (Rfree =
55.1%). Subsequently, the auto-building
program ARP/wARP was used to build
86% of the protein model. Further
model building of the apo form I
structure was achieved using the
program QUANTA. Model refinement
was performed using CNS (Bru¨nger et
al., 1998). A randomly chosen 5% of all
of the measured reflections were set
aside for cross-validation. After itera-
tive rounds of model fitting and refine-
ment, solvent atoms were located
manually using QUANTA. Model
refinement of the apo form II, NAD+-
complex and citrate-complex structures
was also carried out using CNS. Clear
electron density was observed for the
cofactor or citrate bound to the enzyme.
After corrections of the protein model
were almost complete, cofactor or
citrate molecules were added to the
respective model and were refined using
CNS. For the apo form II structure, a
glycerol molecule and sulfate ions were
added near the active site. The topology
and parameter files for NAD+, citrate
and glycerol were obtained from the
Hetero-compound Information Centre
– Uppsala (HIC-Up; Kleywegt & Jones,
1998). The stereochemical quality of all
of the models was checked with
PROCHECK. The refinement statistics
are summarized in Table 1.
Electron density is continuous and
well defined in all the crystal structures,
but in the apo form II crystal structure
amino acids Asp180–Asp189 (the loop
between 6 and 7) in protomer D had
weak density or no density at all. A
residue at the N-terminus was also left
out in all structures, as no well defined
electron density revealing its position
and conformation was observed.
2.6. Model analyses
The DALI server was utilized for a
similarity search against all known
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Figure 2
Sequence alignment of 3-dehydro-2-deoxy-d-gluconate dehydrogenase orthologues. (a) The
secondary-structural elements of T. thermophilus DDGDH are shown above the alignment.
Strictly conserved residues are highlighted. The blue triangles below the sequences mark the key
residues of the catalytic triad (Ser129–Tyr144–Lys148) of the SDR family. TT, Thermus
thermophilus HB8; AT, Arabidopsis thaliana; ML, Mesorhizobium loti MAFF; SU, Solibacter
usitatus; BC, Bacillus clausii KSM-K16, OI, Oceanobacillus iheyensis HTE831; AT, Agrobacterium
tumefaciens C58; TM, Thermotoga maritima MSB8; HM, Haloarcula marismortui ATCC; RX,
Rubrobacter xylanophilus DSM. This figure was drawn with ClustalX (Thompson et al., 1997) and
ESPript (Gouet et al., 1999). (b) Stereoview of the ribbon representation of the DDGDH protomer
with the secondary-structural elements indicated. The N- and C-termini are coloured blue and red,
respectively. The cofactor NAD+ is shown as a ball-and-stick model.
structures deposited in the PDB. Superimposition of protein
models was performed using LSQKAB (Kabsch, 1976). CNS
and the Protein–Protein Interaction Server were used for the
calculation of solvent-accessible surface areas (http://
www.biochem.ucl.ac.uk/bsm/PP/server/). Publication-quality
pictures were generated using PyMOL (Schro¨dinger; http://
www.pymol.org).
2.7. Protein Data Bank accession codes
The atomic coordinates and structure-factor amplitudes
for native form I, native form II, cofactor-bound and citrate-
bound forms of DDGDH have been deposited in the RCSB
Protein Data Bank (http://www.rcsb.org/pdb) with accession
codes 4jp2 (1x1e), 2ekq, 2ekp and 4jp3, respectively.
3. Results and discussion
3.1. Structure determination and model quality
The crystal structure of NAD-dependent DDGDH from
T. thermophilus HB8 in apo form I has been determined at
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Figure 3
Tetrameric interaction of DDGDH. (a) Tetrameric structure of DDGD in
two orthogonal views. Subunits A, B, C and D are coloured cyan, green,
yellow and pink, respectively. The three perpendicular twofold axes (P,Q
and R axes) that generate the 222 point-group symmetry are shown and
labelled. The three interfaces I, II and III indicated by dotted circles are
labelled. (b) The surface diagram of tetrameric DDGDH coloured
differently for different subunits.
1.15 A˚ resolution by the molecular-replacement method
(Bru¨nger et al., 1998). Subsequently, the structures of apo form
II, the cofactor complex and the citrate complex were deter-
mined by the molecular-replacement method using the apo
form I coordinates as a search model and were refined to 1.80,
1.15 and 1.50 A˚ resolution, respectively. The asymmetric units
of the apo form I, NAD-complex and citrate-complex crystals
consist of a single protomer with a calculated Matthews
coefficient (Matthews, 1968) VM of 2.5 A˚
3 Da1, whereas the
apo form II asymmetric unit consists of four subunits with a
Matthews coefficient VM of 2.9 A˚
3 Da1. Continuous signifi-
cant electron density was observed for main-chain atoms, and
the atomic model for residues 2–239 could easily be estab-
lished. Analysis of the stereochemistry using PROCHECK
(Laskowski et al., 1993) shows that 89.9% of the residues are in
the favoured regions and 10.1% are in additionally allowed
regions of the Ramachandran plot. No residues lie in the
generously allowed or disallowed regions. The refined model
has very low R values and excellent geometry. Refinement
statistics and the model quality are summarized in Table 1.
3.2. Overall structure of DDGDH protomer
The DDGDH protomer forms a globular structure
consisting of seven -strands (named 1–7) and eight
-helices (named 1–8) (Figs. 2a and 2b). The protomer of
DDGDH contains a slightly modified Rossmann-fold motif,
with a twisted parallel seven-stranded -sheet (1–7) flanked
on both sides by four parallel -helices (1, 2, 3, 8 and 4–
7) located on each side of the -sheet, and can be described
as a doubly wound / structure. This folding pattern has been
referred to as a basic / SDR fold (Varughese et al., 1992).
Three longer helices (4, 5 and 6) form the interfacial four-
helix bundle typical of dimeric and tetrameric SDR proteins.
The conservation of the overall fold of SDR family proteins in
DDGDH, despite the low sequence similarity, suggests that
the overall fold may be conserved among all SDR family
proteins.
The apo-form structure could be superimposed on the
cofactor-complex and citrate-complex structures with a root-
mean-square deviation (r.m.s.d) of less than 0.28 A˚ for the
main-chain atoms. These low r.m.s.d. values indicate that
binding of the cofactor or citrate does not lead to significant
conformational changes in the enzyme.
3.3. Tetrameric quaternary structure
Crystallographic analyses reveal that DDGDH exists as an
apparent tetramer stabilized by extensive interfaces in the
crystal. Notably, all of the crystal forms contain globally
identical tight tetramers with approximate dimensions of
73.5  68.5  60.5 A˚ (Fig. 3a). The observed tetramers are
consistent with the results of our dynamic light-scattering
measurements, which suggested that DDGDH is predomi-
nantly tetrameric in solution (see x2). These observations
suggest that DDGDH functions as a homotetramer (Fig. 3b).
The asymmetric unit of the apo form II crystal contains four
subunits of DDGDH related by noncrystallographic 222
point-group symmetry mediated by three perpendicular
twofold axes that are conventionally termed the P, Q and R
axes (Rossmann et al., 1973; Fig. 3a; the subunits are denoted
as chains A, B, C and D). The four subunits exhibit essentially
identical overall structures, with root-mean-square deviation
(r.m.s.d.) values between equivalent C atoms of subunits A,
B, C and D of about 0.28 A˚. We define the interface between
subunitsA and B as interface I, that between subunitsA and C
as interface II and that between subunits A and D as interface
III (Fig. 3a). The surface areas that are buried on the forma-
tion of interfaces I and II are 1470 and 1492 A˚2, corresponding
to 13.7 and 13.9% of the total protomer surface area,
respectively. Interface III buries a minor area of 354 A˚2. The
solvent-accessible surface areas for the isolated protomer,
dimer and tetramer were calculated to be 10 853, 18 551 and
30 225 A˚2, respectively. The major interface I mediated by
residues of the 5 and 6 helices is in the vicinity of the active
site (catalytic triad). The interacting surface at interfaces I and
II are essentially hydrophobic. Interface I consists of aromatic
interactions and is surrounded by 18 polar interactions. On the
other hand, interfaces II and III (residues between 5 and 6,
between 7 and 8, and between 8 and residues at the
C-termini) are dominated by eight and four hydrogen bonds,
respectively. We mapped the highly conserved residues in
DDGDH orthologues onto the molecular surface, which
clearly revealed a conserved pattern (not shown). Interfaces I
and II include the invariant residues Glu161, Pro200 and
Arg203 (Fig. 2a). This result may indicate the biological
importance of these residues in the catalytic function or in
maintaining the integrity of the AB and AC dimeric interfaces.
The minor interface does not contain invariant residues,
indicating that residue conservation is not necessarily
required. Invariant residues might contribute to the thermo-
stability of the protein, as reported for the dimeric/tetrameric
2-deoxyribose-5-phosphate aldolase (Lokanath et al., 2004).
The association of monomers into a dimer is accomplished
by the four-helix bundle which is formed by helices 5 and 6
of the respective subunits. The 5 and 6 helices from one
protomer are in contact with the corresponding helices from
the other protomer, such that the helices from different
protomers are nearly antiparallel.
3.4. Structural comparison with other dehydrogenases
A three-dimensional structural similarity search utilizing
the DALI server (Holm & Sander, 1993) was performed
between the refined models of the DDGDH protomers and
the coordinates available in the Protein Data Bank (PDB).
The search revealed several enzymes belonging to the SDR
family fold with Z-scores of 32.2–15.2 and with r.m.s.d. values
of 1.5–2.4 A˚. The enzyme structurally most similar to
DDGDH is carbonyl reductase from mouse lung (MLCR;
Tanaka et al., 1996; 28% sequence identity; PDB entry 1cyd;
Z-score 32.2; r.m.s.d. of 1.5 A˚ for 233 C atoms). Fig. 4 shows a
superimposition of the DDGDH and MLCR structures. Most
of the secondary-structural elements are conserved between
these two enzymes, although they show a few apparent
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differences. The main structural differences are observed at
helix 3, between 2 and 2, and in the loop between 6 and
6. Thus, our result is consistent with the assumption that
DDGDH belongs to the SDR family. Similar structures with a
nucleotide-binding domain obtained in the DALI search are
listed in Table 2.
3.5. Cofactor NAD binding at the intersubunit cleft
Most of the NAD/NADP-dependent dehydrogenases of the
SDR family share a common framework (a Rossmann fold)
for binding the dinucleotide cofactor (Rossmann et al., 1974),
including an extended consensus sequence TGXXXGXG at
the N-terminus. We analyzed the crystal structure of DDGDH
complexed with NAD+ determined by the molecular-repla-
cement method at 1.15 A˚ resolution. Thanks to the high
resolution of the structure, we could establish a complete
atomic model of the bound NAD+ (Fig. 5a) and all of the
residues and solvent molecules that directly interact with
NAD+ (Fig. 5b). The NAD+ molecule is bound in the inter-
subunit cleft between the two protomers of the dimer, and is
placed at the top of the parallel seven-stranded -sheet in an
extended conformation. The cofactor interacts directly with
the adjacent subunit (Fig. 5c). Thus, NAD+ plays an important
role in the oligomeric state of DDGDH. The adenine and
nicotinamide rings are oriented roughly perpendicular to the
planes of the riboses, resulting in an anti conformation for the
adenine ring and a syn conformation for the nicotinamide ring.
The high-resolution electron-density map allowed the unam-
biguous identification of the C20-endo conformation for both
of the ribose rings. The distance between C6 of the adenine
ring and C2 of the nicotinamide ring is 14.4 A˚, which is very
close to those found in various other SDR enzymes. The
conformational properties of the bound NAD+ are also
common to most SDR enzymes (Didierjean et al., 1997).
Amino-acid residues of the conserved SDR motifs, such as
Asp51, Ser129, Tyr144 and Lys148, are in close contact with
NAD+. Furthermore, Ser11 and Glu118 (from the other
subunit) form hydrogen bonds to the O30 and O20 hydroxyl
groups of the adenine ribose moiety of the dinucleotide, with
bond lengths of 2.7 and 2.6 A˚, respectively (Fig. 5c). This
region determines the specificity towards NAD(H) over
NADP(H), since the side chains of Ser11 and Glu118 (from
the other subunit) would come into unacceptably close contact
with the 20-phosphate group of the adenosine moiety of
NADP(H). Our crystal structure indicates that T. thermo-
philus DDGDH prefers NAD rather than NADP. The
cofactor involved in hydrogen bonding to the adjacent subunit
is highly specific to DDGDH, indicating a novel cofactor
interaction of the SDR family. Of the catalytic triad Ser129–
Tyr144–Lys148, Tyr144 and Lys148 hydrogen-bonded to O20
and O30 of the nicotinamide ribose moiety of the dinucleotide,
with bond lengths of 2.69 and 2.90 A˚, respectively. Strikingly,
the residues responsible for cofactor recognition are not well
conserved among the DDGDH orthologues except for the
catalytic triad residues Tyr144, Lys148 and Asp51. These
residues are important determinants of the
interaction with NAD+.
3.6. The active site (citrate, glycerol and
sulfate binding)
Attempts to co-crystallize DDGDH with
KDG yielded crystals of the citrate complex.
The reservoir solution used for crystal-
lization contained 0.5M citrate–HCl. We
analyzed the crystal structure of DDGDH
complexed with the citrate molecule deter-
mined by the molecular-replacement
method at 1.50 A˚ resolution. In this
complex, the asymmetric unit contains a
protomer of DDGDH. Superposition of the
protomer structures of the citrate complex
and apo form I results in an r.m.s.d. of
0.28 A˚, indicating that the structures are
very similar in spite of their different
packing in the crystals. The citrate molecule
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Figure 4
Stereoview of a superimposition of the DDGDH and MLCR subunit structures. DDGDH
is coloured yellow and MLCR red. Differences at the main-chain level between the two
structures are circled with green broken lines.
Table 2
R.m.s. deviations compared with DDGDH (PDB entry 4jp2).
Enzyme† Z-score R.m.s.d (A˚) Residues fitted Sequence identity (%)
1cyd 32.2 1.5 233 28
1ybv 29.8 2.1 229 28
1e6w 28.4 1.9 216 25
1e7w 28.1 2.1 227 31
1bdb 27.5 2.0 222 26
1zmt 26.8 2.4 225 24
1gz6 26.6 2.3 207 28
† The enzymes are listed by their PDB entries: 1cyd, carbonyl reductase from mouse
(Tanaka et al., 1996); 1ybv, trihydroxynaphthalene reductase from Magnaporthe grisea
(Andersson et al., 1996); 1e6w, 3-hydroxyacyl-CoA dehydrogenase from Rattus
norvegicus (Powell et al., 2000); 1e7w, pteridine reductase from Leishmania major
(Gourley et al., 2001); 1bdb, cis-biphenyl-2,3-dihydrodiol-2,3-dehydrogenase from
Pseudomonas sp. (Hulsmeyer et al., 1998); 1zmt, haloalcohol dehalogenase from
Agrobacterium radiobacter (de Jong et al., 2005; 1gz6, (3R)-hydroxyacyl-CoA
dehydrogenase type 2 (from rat; Haapalainen et al., 2003 ).
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is bound to the active site of DDGDH (Fig. 6a) and makes
hydrogen bonds to the active-site (catalytic triad) residues
(Fig. 6d). Therefore, it is likely that the citrate molecule and
the substrate DDG share the same binding pocket. The citrate
molecule is associated with one subunit. The chemical struc-
tures of citrate and DDG are very similar (Fig. 7a), and thus
citrate may be regarded as a substrate analogue. The citrate
molecule interacts with the side chains of Asn81, Arg83,
Ser129 and Tyr144 and the main-chain O atom of Gly175
(Fig. 6d). Of the three carboxyl groups of the citrate, the C1
carboxylate group makes hydrogen bonds to the side chains
of Asn81 and Arg83, while the C2 carboxyl group makes
hydrogen bonds to the side chains of the catalytic triad resi-
dues Ser129 and Tyr144, and the C3 carboxyl group makes
hydrogen bonds to the main-chain O atom of Gly175. The
orientation of the citrate molecule is optimal for catalysis
because the catalytically important Ser129 and Tyr144 interact
with the C2 carboxyl group. To attempt to determine the DDG
binding mode in the substrate-binding pocket unambiguously,
the equivalent substrate KDG was added to mother liquor
containing crystals of the apo forms, cofactor complex or
citrate complex of DDGDH. However, the crystals were
severely damaged upon addition of the substrate, implying
substantial ligand-induced conformational changes.
In the apo form II crystal, the active site is occupied by
glycerol and sulfate molecules (Fig. 6b). The reservoir solution
used for crystallization contained 1.0M ammonium sulfate
and the crystal was cryoprotected using 30% glycerol. The
glycerol molecule interacts with the side chain of Ser129 of the
catalytic triad and the sulfate molecule. The O2 atom of the
glycerol molecule makes a hydrogen bond to the side chain of
Ser129 and the O4 atom of the sulfate molecule (Fig. 6e). The
sulfate molecule interacts with the side chain of Ser129,
Tyr144, the main chain of Gly128 and the glycerol molecule.
The O4 atom of the sulfate molecule makes a hydrogen bond
to the side chain of Ser129, Tyr144, the main-chain O atom of
Gly128 and the O2 atom of the glycerol molecule. We also
observed a strong positive peak in the Fo Fc electron-density
Figure 5
Binding of the cofactor near the active site of DDGDH. (a) 2Fo  Fc electron-density map of NAD+ at 1.15 A˚ resolution at a 1.2 contour level. (b)
Structural surroundings of the NAD+ molecule. (c) NAD+ molecule located at the intersubunit cleft. Ser129, Tyr144 and Lys148 from the catalytic triad
required for the hydride-transfer reaction. In the structure of DDGDH, the close contact of Ser11 and Glu118 from the other subunit with the hydroxyl
groups of adenine ribose does not leave sufficient space for the phosphate group of NADP(H). This guides the specificity towards NAD(H). The subunits
shown are coloured green and yellow, respectively.
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Figure 6
Binding of the citrate, glycerol and sulfate molecules at the active site of DDGDH. (a) Simulated OMIT map of citrate (bound at the active site) at 1.5 A˚
resolution at a 1.0 contour level. (b) Simulated OMIT map of glycerol and sulfate ion (bound to the apo form II crystal) at 1.8 A˚ resolution at a 0.9
contour level. (c) Fo  Fc negative electron-density map at the active site of the apo form I crystal at 1.15 A˚ resolution. Catalytic triad residues are
labelled. (d) Residues around the citrate molecule. Important hydrogen bonds are indicated by broken lines. (e) Residues around the glycerol and sulfate
ion (bound to apo form I). Catalytic triad residues are labelled.
map in the vicinity of the active site of apo form I, indicating
the presence of substrate (Fig. 6c). However, we could not
model the substrate (only the hydroxyl group was very clear)
owing to a lack of clear density for the substrate.
3.7. Substrate recognition and catalytic machinary
To understand how the substrate is recognized by T. ther-
mophilus DDGDH, we made an attempt to fit the substrate
KDG (the chemical structures of DDG and KDG are highly
similar) into the active-site pocket on the basis of the binding
of citrate, glycerol and sulfate molecules. In our modelling
efforts, it was clear that the substrate fits well into the
substrate-binding pocket (Ohshima et al., 2004). The dehy-
drogenase activity of the SDR family enzymes has been well
studied (Jo¨rnvall et al., 1995; Ghosh et al., 2001; Filling et al.,
2002). There is a conserved catalytic triad, Ser129–Tyr144–
Lys148, in the catalytic site, with the tyrosine residue (Tyr144)
functioning as the catalytic base abstracting a proton from the
substrate. The serine (Ser129) plays a role in the stabilization
of the bound substrate, and the lysine
(Lys148) directly interacts with the
hydroxyl of the tyrosine residue through
the 20-hydroxyl of the nicotinamide
ribose of the cofactor and lowers its pKa
value (Jo¨rnvall et al., 1995; Ghosh et al.,
2001; Filling et al., 2002). This catalytic
triad is structurally well conserved in
DDGDH, suggesting that DDGDH
follows a similar catalytic mechanism.
We were not able to obtain the complex
with KDG. However, citrate, glycerol
and sulfate molecules binding at the
active site provided the structural
environment at the substrate-binding
site. Since no structural changes were
observed between the native structure
and those of the NAD+ complex and the
citrate complex, we could construct a
putative model of the DDGDH–citrate–
NAD+ ternary complex by super-
imposing the two structures (the r.m.s.d
is 0.19 A˚). Moreover, the cofactor-
complex and citrate-complex crystals
are isomorphous and share the same
space group, even though they were
crystallized in different conditions. The
chemical structures of citrate and DDG
are highly similar (Fig. 7a), and thus
citrate may be regarded as a substrate.
The initiation of the catalytic reaction is
the abstraction of a proton from the C1
hydroxyl of the citrate by Tyr144 in
combination with Ser129 and Lys148.
Hydride transfer subsequently occurs
from the C1 hydroxyl of the citrate
molecule to C4 of the nicotinamide ring
of the cofactor NAD+ directly (Fig. 7b).
In the putative model of the ternary
complex, the distance between the C1
hydroxyl of the citrate molecule and C4
of the nicotinamide ring is approxi-
mately 3.9 A˚ and the N—C4—C1 angle
is 115. These values are consistent
with those obtained from theoretical
considerations of hydride transfer and
those observed in a number of struc-
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Figure 7
A proposed model for substrate binding to T. thermophilus DDGDH. (a) Chemical structures of
citrate, 2,5-diketo-3-deoxygluconate (DDG) and 2-keto-3-deoxygluconate (KDG). (b) Stereoview
(modelled) of the binding of citrate and NAD+ to DDGDH. (c) Stereoview (modelled) of the
binding of 2-keto-3-deoxygluconate to NAD-dependent DDGDH. Ser129, Tyr144 and Lys148 in
this figure constitute the catalytic triad in T. thermophilus DDGDH.
tures of NAD(P)-dependent enzymes (Wu & Houk, 1991). In
a similar fashion, our modelled substrate KDG also has
identical bond lengths and angles to the cofactor and the
catalytic triad, suggesting a similar catalytic mechanism
(Fig. 7c).
In this study, we determined the three-dimensional crystal
structure of T. thermophilus NAD-dependent DDGDH and
its complex with citrate for the first time. The cofactor NAD+
molecule was bound at the cleft between the two adjacent
subunits. The citrate molecule is located in the active site
(catalytic triad). It is likely that citrate and the substrate KDG
share the same binding pocket. The observed intersubunit
active site comprising both subunits of the AB dimer suggests
the catalytic importance of the oligomeric state. The active site
and the cofactor-binding site have been identified deep in the
cleft formed between the intersubunit interface. The identifi-
cation of the active site and structural comparison with a
homologous enzyme suggests that the SDR scaffold with the
Ser129–Tyr144–Lys148 catalytic triad is conserved. The
observed binding mode of the citrate molecule and cofactor
provide insights into the substrate recognition and catalytic
machinery of DDGDH.
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